Johnston, C., Brown, E. R., Stewart, J., Karita, H. C., Kissinger, P. J., Dwyer, J., Hosek, S., Oyedele, T., Paasche-Orlow, M. K., Paolino, K., Heller, K. B., Leingang, H., Haugen, H. S., Dong, T. Q., Bershteyn, A., Sridhar, A. R., Poole, J., Noseworthy, P. A., Ackerman, M. J., Morrison, S., Greninger, A. L., Huang, M., Jerome, K. R., Wener, M. H., Wald, A., Schiffer, J. T., Celum, C., Chu, H. Y., Barnabas, R. V., Baeten, J. M., & , (2021). hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial. EClinicalMedicine, 33, . http://access.bl.uk/ark:/81055/vdc_100124368934.0x000004